Analysis

  • Preventing the Fallout: Anti-Radiation Drugs

    The disaster at the Fukushima nuclear plant in Japan has triggered demand for a powerful anti-radiation drug. Elisabeth Fischer finds out what options are currently out there and asks just...

  • HIV: Hope on the Horizon?

    Treatment for HIV / Aids is more sophisticated than ever, but how much closer are we to finding a cure? Chris Lo investigates the colossal challenges for organisations trying to...

  • The War Against Counterfeit Drugs

    The real danger of counterfeit medicine is not the profit loss for the industry, but the threat to patient health. Elisabeth Fischer speaks to pharmaceutical labelling and identification specialist Ray...

  • At War With Antimicrobial Resistance

    As quick as we can conquer them, disease-causing microbes themselves are finding new ways to fight the drugs. Dr Gareth Evans reports on what is arguably the most serious and...

  • Pharma Regulation: Quality by Design?

    The fragmentation of pharmaceutical regulation is detrimental to both industry and the patients it serves. Chris Lo looks at the organisations trying to bring about a more unified process for...

  • Standardised Pricing Strategies in Clinical Trials

    Fixed pricing strategies are said to provide higher transparency in outsourcing clinical trials. Elisabeth Fischer spoke to Wolfgang Eglmeier, head of clinical operations at Grünenthal in Germany, about the trends...

Close
Close
Close

Go Top